Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nurfarhanah Bte Syed Sulaiman"'
Autor:
Sharon Yin Yee Low, He Cheng, Ruiyang Zou, Lee Ping Ng, Chik Hong Kuick, Nurfarhanah Bte Syed Sulaiman, Kenneth Tou En Chang, David Chyi Yeu Low, Lihan Zhou, Wan Tew Seow
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Germinomas (IG) account for up to 50% of all intracranial germ cell tumours. These tumours are reputed to be more prevalent in Oriental populations in comparison to Western cohorts. Biological characteristics of IG in other ethnic
Externí odkaz:
https://doaj.org/article/d8513f3f738e471b9ac2d554c0cb66a9
Autor:
Wan Tew Seow, Chik Hong Kuick, Ruiyang Zou, Lihan Zhou, Nurfarhanah Bte Syed Sulaiman, David C. Y. Low, Sharon Y.Y. Low, Lee Ping Ng, He Cheng, Kenneth Tou En Chang
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Neurology
BMC Neurology
BackgroundGerminomas (IG) account for up to 50% of all intracranial germ cell tumours. These tumours are reputed to be more prevalent in Oriental populations in comparison to Western cohorts. Biological characteristics of IG in other ethnic groups ar
Autor:
Mei Yoke Chan, Yvonne F. L. Yong, Derrick W. Q. Lian, Zhi Xiong Chen, Enrica E. K. Tan, Michaela S. F. Seng, Sharon Ling, Min Hwee Yong, Prasad Iyer, Yong Chen, Eileen H. Q. Ng, Yong Wei Chua, Esther Hee, Meng Kang Wong, Joyce Ching Mei Lam, Muhammad Fahmy Syed, Mee Hiong Ren, Amos Hong Pheng Loh, Sharon Y.Y. Low, Tony Kiat Hon Lim, Chik Hong Kuick, Kenneth Tou En Chang, Sudhanshi Jain, Sheng Hui Tan, Zhang'e Choo, Shui Yen Soh, Ah Moy Tan, Nurfarhanah Bte Syed Sulaiman
Publikováno v:
Cancer Science
Ex vivo evaluation of personalized models can facilitate individualized treatment selection for patients, and advance the discovery of novel therapeutic options. However, for embryonal malignancies, representative primary cultures have been difficult
Autor:
Sharon Low, Nurfarhanah Bte Syed Sulaiman, Kheng Wei Yeoh, Enrica Tan, Kenneth Chang, Ru Xin Wong, Wen Shen Looi, Wan Tew Seow
Publikováno v:
WFNOS 2022 Abstract Book.
Autor:
Nurfarhanah Bte Syed Sulaiman, Wan Tew Seow, Kenneth Te Chang, Kai Rui Wan, Wen Shen Looi, Sharon Y.Y. Low, David C.Y. Low, Chik Hong Kuick
Publikováno v:
NeuroSci
Volume 2
Issue 1
Pages 6-108
Volume 2
Issue 1
Pages 6-108
Pilocytic astrocytomas (PCA) are WHO Grade I tumors with a favorable prognosis. Surgical resection is usually curative. Nonetheless, progressive and/or metastatic disease occurs in 20% of patients. For these patients, treatment options are limited. T
Autor:
Low, Sharon Yin Yee, Cheng, He, Ruiyang Zou, Ng, Lee Ping, Chik Hong Kuick, Nurfarhanah Bte Syed Sulaiman, Chang, Kenneth Tou En, Low, David Chyi Yeu, Lihan Zhou, Seow, Wan Tew
Additional file 1: Supplementary Data A. miRDB search result for miR-221-3p.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::638d1149f5d84f7f43664612e3bca80d
Autor:
Tuan Zea Tan, Jianzhou Cui, Prashali Bansal, John M. Lamar, Madhura Kulkarni, Nurfarhanah Bte Syed Sulaiman, Yoshiaki Ito, Yiting Qiao
Publikováno v:
Oncotarget
Hippo pathway target, YAP has emerged as an important player in solid tumor progression. Here, we identify RUNX1 and RUNX3 as novel negative regulators of oncogenic function of YAP in the context of breast cancer. RUNX proteins are one of the first t
Autor:
Kanchugarakoppal S. Rangappa, Nurfarhanah Bte Syed Sulaiman, Shobith Rangappa, Vijay Pandey, Peter E. Lobie, Alan Prem Kumar, Chakrabhavi Dhananjaya Mohan, Hanumantharayappa Bharathkumar, Salundi Basappa
Publikováno v:
International Journal of Oncology. 49:1221-1229
Persistent activation of signal transducer and activator of transcription 3 (STAT3) is associated with the progression of a range of tumors. In this report, we present the anticancer activity of 2-(1-(4-(2-cyanophenyl)1-benzyl‑1H-indol-3-yl)-5-(4-m
Autor:
Madhura Kulkarni, Wanjin Hong, Thomas C. Putti, Yoshiaki Ito, Soo-Chin Lee, Supriya Srivastava, Tuan Zea Tan, Nurfarhanah Bte Syed Sulaiman, Xiaomeng Wang
Publikováno v:
Molecular Cancer Research. 18:B02-B02
Triple-negative breast cancer (TNBC) is considered one of the aggressive breast cancer subtypes with higher risk of recurrence and mortality compared to other subtypes. There is a need to identify molecular markers and drivers that could distinguish